Cm Management, LLC Cytosorbents Corp Transaction History
Cm Management, LLC
- $107 Million
- Q4 2024
A detailed history of Cm Management, LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Cm Management, LLC holds 700,000 shares of CTSO stock, worth $707,000. This represents 0.59% of its overall portfolio holdings.
Number of Shares
700,000
Previous 800,000
12.5%
Holding current value
$707,000
Previous $1.2 Million
47.5%
% of portfolio
0.59%
Previous 1.01%
Shares
14 transactions
Others Institutions Holding CTSO
# of Institutions
58Shares Held
15.7MCall Options Held
16KPut Options Held
0-
Avenir Corp Washington, DC3.09MShares$3.12 Million0.29% of portfolio
-
Skylands Capital, LLC2.78MShares$2.81 Million0.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.97 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$1.7 Million0.0% of portfolio
-
Sargent Investment Group, LLC1.25MShares$1.26 Million0.18% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $44M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...